BNET Industries

Nephros Inc.

(NEP) is in the Health Care Industry

Market Cap:$147.3M
Last Fiscal Year Sales:$1.1M
  • Public
  • US
Dow Jones Description

Nephros, Inc. engages primarily in the development of hemodiafiltration (HDF) products and technologies for treating patients with end stage renal disease.

President & Chief Executive Officer
Ernest A. Elgin III
Number of Employees 9
Contact Information

3960 Broadway

New York, New York 10032

www.nephros.com

1 212 896 1250

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

Recent Events

  • Nephros Reports 2009 Third Quarter Financial Results

    11/12/09 - Financial Announcement - View Story

  • Nephros Awarded $2 Million Contract Expansion by the Office of Naval Research

    8/31/09 - Joint Venture / Alliance - View Story

  • Nephros Reports 2009 Second Quarter Financial Results

    8/14/09 - Financial Announcement - View Story

News & Analysis

amex and nephros inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Ernest A. Elgin III President & Chief Executive Officer
Mark W. Lerner CFO
Jan Rehnberg Vice President, Marketing, Sales
Lee Henderson Vice President, Scientific Affairs
Cormac Mohan Director, Operations
Patrice Zyry Director, Services
Dara Gannon Customer Service Manager, Customer Service
Gregory Collins Manager
Pat O'Donnel Finance Manager
Steve Adler Marketing Manager
Bruce Prashker
Detlef Krieter
John T Daugirdas
Leonard Stern
Donald G. Drapkin Director
Eric A. Rose Director

Board of Directors

Name (plus bio) Position
James S. Scibetta Chairman
William J. Fox Chairman
Bernard Salick Board of Directors
Howard Davis Board of Directors
Lawrence J. Centella Board of Directors
W. Townsend Ziebold Jr. Board of Directors

Organization Position Status
Nephros, Inc. President & Chief Executive Officer Current

Organization Position Status
Nephros, Inc. CFO Current

Organization Position Status
Nephros, Inc. Vice President, Marketing, Sales Current

Organization Position Status
Nephros, Inc. Vice President, Scientific Affairs Current

Organization Position Status
Nephros, Inc. Director, Operations Current
Gambro Healthcare, Inc. Chief Operating Officer Former
Gambro Healthcare, Inc. Executive Vice President Former
Nephros, Inc. Director, Operations Former

Organization Position Status
Nephros, Inc. Director, Services Current
Nephros, Inc. Director, Services Former

Organization Position Status
Nephros, Inc. Customer Service Manager, Customer Service Current

Organization Position Status
Nephros, Inc. Manager Current
University of California, San Diego Ph.D. in Bioengineering Former
Menlo College BS in Business Administration Former

Organization Position Status
Nephros, Inc. Finance Manager Current

Organization Position Status
Nephros, Inc. Marketing Manager Current

Organization Position Status
Nephros, Inc. Current
Deloitte Touche Tohmatsu Former
Revlon, Inc. Former

Organization Position Status
Nephros, Inc. Current

Organization Position Status
Nephros, Inc. Current
Columbia University Assistant Professor Former

Organization Position Status
Nephros, Inc. Current
Columbia University Assistant Professor of Clinical Medicine Former

Organization Position Status
Nephros, Inc. Chairman Current
Nephros, Inc. Board of Directors Current
Bioenvision, Inc. Chief Financial Officer Former
Merrimack Pharmaceuticals, Inc. Chief Financial Officer Former
Merrimack Pharmaceuticals, Inc. Executive Vice President Former
Labopharm Inc. chairman Former
University of Michigan M.B.A in Finance Former
Wake Forest University B.S. in physics Former

Organization Position Status
Lq Corp, Inc. President, Chief Executive Officer and Director Current
Nephros, Inc. Chairman Current
Lq Corp, Inc. Director Former
Sielox Inc Director Former

Organization Position Status
Nephros, Inc. Board of Directors Current

Organization Position Status
Rre Ventures LLC Senior Advisor Current
Brandeis University Trustee Current
American Lawyer Media, Inc. Director Current
Weddingchannel.Com, Inc. Chairman Current
Trans Tech Pharma Board of Directors Current
Revlon Consumer Products Corp. Director Current
The Warnaco Group, Inc. Director Current
Skadden, Arps, Slate, Meagher & Flom LLP Partner Former
Cravath, Swaine & Moore LLP Attorney Former
Pharmacore, Inc. Board Director Former
Revlon, Inc. Director Current
SIGA Technologies, Inc. Board of Directors Former
MacAndrews & Forbes Holdings Inc. Vice Chairman Former
MacAndrews & Forbes Holdings Inc. Director Former

Array

Organization Position Status
Siga,Inc. Chief Executive Officer Current
Trans Tech Pharma Medical Leader, Heart Surgeon, Researcher, and Entrepreneur Current
Quantiamd Chairman, Columbia University Department of Surgery. Current
SIGA Technologies, Inc. Chairman of the Board Current
Siga,Inc. Chairman of the Board Current
Nephros, Inc. Director Current
Trans Tech Pharma Board of Directors Current
Scius Capital Group LLC Board of Directors Current
World Product Centre Board of Directors Current
Sciedunet Board of Directors Current
ABIOMED, Inc. Board of Directors Current
Pharmacore, Inc. Board of Directors Current
Surgical Services, Inc Director Current
SIGA Technologies, Inc. Director Current
Keryx Biopharmaceuticals, Inc. Director Current
Nephros, Inc. CEO Former
Nephros, Inc. President Former
Trans Tech Pharma Co-Founder Former
SIGA Technologies, Inc. Principal Executive Officer Former
Siga,Inc. Director Former
Columbia College Bachelor's Degree Former
Kbl Healthcare, Inc. Chairman Current
Stanford University postgraduate training in general surgery and Cardio, Thoracic surgery Former

Organization Position Status
Nephros, Inc. Board of Directors Current

Organization Position Status
Nephros, Inc. Board of Directors Current

Organization Position Status
Nephros, Inc. Board of Directors Current

Executive News

  • Nephros Receives 510k Approval for Dual Stage Ultrafilters

    PR Newswire - 7/02/09 - View Story

advertisement
     NEP $5.77 +0.07 (1.23% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 403,404
Shares Outstanding 25.85M
Market Cap 149.2M
Year High 6.5
Year Low 0.07
Earnings Per Share 0.78
P/E Ratio 7.40
Dividend N/A
Yield N/A
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement